Home / Inspections / 1024599

FDA Inspection 1024599 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006188513

The FDA completed an inspection of Octapharma Plasma, Inc. on August 24, 2017 in Springfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Springfield, IL (United States)

Facility

Other inspections at this facility

  • 1198041 (NAI Thu Jan 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106647 (NAI Wed Jul 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944107 (NAI Mon Sep 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 818220 (NAI Fri Jan 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 716428 (NAI Thu Mar 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources